It is testing a new, low global warming potential ... "Are dry powder inhalers the key to sustainable respiratory care?" was originally created and published by Medical Device Network, a ...

GSK has developed a new propellant technology for inhaler devices that drastically ... chronic obstructive pulmonary disease and other respiratory diseases currently use hydrofluorocarbon (HFC ...

So, a lot of the same options for children with asthma are available as an adult with asthma. A lot of them are the exact same. There just might be a different dosage. So, more recently, the ...

“The work we are doing with AstraZeneca developing a respiratory inhaler, with a new near-zero Global Warming Potential propellant, is tremendously important for both the environment and ...

potentially decreasing the reliance on inhalers for everyday symptom control among the 7 million UK residents living with this respiratory ailment. Published in the Journal of Allergy and Clinical ...

Opens in a new tab or window Share on Bluesky ... Source Reference: Jabaudon M, et al "Inhaled sedation in acute respiratory distress syndrome: The SESAR randomized clinical trial" JAMA 2025 ...

If you're new to using inhalers, no matter your condition ... According to Elaine Fajardo, MD, Medical Director for Respiratory Therapy and Pulmonologist at Yale Medicine, and Assistant Professor ...

Chiesi Group, a global biopharmaceutical company headquartered in Parma, Italy, has announced a major investment in Nerviano (Milan, Italy), with the construction of a new facility for the production ...

More than a thousand of these were given a new inhaler to manage their condition ... but also for the resources of the NHS Professor Jørgen Vestbo Professor of Respiratory Medicine at The University ...

A review of the literature was conducted to examine the clinical effectiveness of inhaled GSH as a treatment for various pulmonary diseases and respiratory-related conditions. This report also ...